menu
    • menu

    Company profile for NITTO DENKO CORP

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Since our foundation in 1918, the Nitto Group has swiftly identified market needs and based on our key technologies, such as adhesives and coating, we have conducted business globally across various industries including electronics, automotive, housing, infrastructure, environmental, and medical. In recent years, we have dedicated ourselves to minimizing our environmental impact and reducing various “social costs” arou...
    Since our foundation in 1918, the Nitto Group has swiftly identified market needs and based on our key technologies, such as adhesives and coating, we have conducted business globally across various industries including electronics, automotive, housing, infrastructure, environmental, and medical. In recent years, we have dedicated ourselves to minimizing our environmental impact and reducing various “social costs” around the world, for example, creating products which reduce medical costs for the aging populations of developed countries. These are both indispensable to maintaining sustainable economic growth.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NITTO DENKO CORPjapan Flag
    Country
    Country
    Japan
    Address
    Address
    33rd Floor, Grand Front Osaka, 4-20, Ofuka-cho, Kita-ku, Osaka 530-0011
    Telephone
    Telephone
    +81-6-7632-2101
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nitto.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Japan lays focus on early detection of heart diseases
    Japan lays focus on early detection of heart diseases

    06 Sep 2021

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/18969/japan-lays-focus-on-early-detection-of-heart-diseases.html

    BIOSPECTRUM ASIA
    06 Sep 2021
    Share Share
    Japan lays focus on early detection of heart diseases
    Japan lays focus on early detection of heart diseases

    06 Sep 2021

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/18969/japan-lays-focus-on-early-detection-of-heart-diseases.html

    BIOSPECTRUM ASIA
    06 Sep 2021
    Share Share
    Bristol-Myers Squibb: Opdivo Meets Primary Endpoint Of Overall Survival
    Bristol-Myers Squibb: Opdivo Meets Primary Endpoint Of Overall Survival

    11 Nov 2016

    // NASDAQ

    http://www.nasdaq.com/article/bristolmyers-squibb-opdivo-meets-primary-endpoint-of-overall-survival-20161110-00377?

    NASDAQ
    11 Nov 2016
    Share Share
    Bristol-Myers pens $100M NASH, fibrosis drug deal with Japan’s Nitto
    Bristol-Myers pens $100M NASH, fibrosis drug deal with Japan’s Nitto

    10 Nov 2016

    // Ben Adams FIERCE BIOTECH

    http://www.fiercebiotech.com/biotech/bristol-myers-pens-100m-nash-fibrosis-drug-deal-japan-s-nitto

    Ben Adams FIERCE BIOTECH
    10 Nov 2016
    Share Share
    Nitto Signs Partnership Agreement with Daiichi Sankyo
    Nitto Signs Partnership Agreement with Daiichi Sankyo

    10 May 2016

    // BUSINESS WIRE

    http://www.businesswire.com/news/home/20160510005036/en/Nitto-Signs-Partnership-Agreement-Daiichi-Sankyo

    BUSINESS WIRE
    10 May 2016
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact NITTO DENKO CORP and get a quotation

    NITTO DENKO CORP is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Oligonucleotide bulk offered by NITTO DENKO CORP

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search